Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects.
暂无分享,去创建一个
N Rifai | D F Dinges | P. Ridker | D. Dinges | N. Rifai | J. Mullington | N. Price | P M Ridker | J M Mullington | H. Meier-Ewert | H K Meier-Ewert | N Price | Hans K. Meier-Ewert | N. J. Price | David F. Dinges
[1] N Rifai,et al. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. , 2001, Clinical chemistry.
[2] J. Strong,et al. Association of Coronary Heart Disease Risk Factors with microscopic qualities of coronary atherosclerosis in youth. , 2000, Circulation.
[3] J. Danesh,et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses , 2000, BMJ : British Medical Journal.
[4] N. Herity. Interleukin 6: a message from the heart , 2000, Heart.
[5] P. Ridker,et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.
[6] N Rifai,et al. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. , 1999, Clinical chemistry.
[7] S. Meri,et al. Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11. , 1999, Journal of immunology.
[8] D. Papanicolaou,et al. Circadian interleukin-6 secretion and quantity and depth of sleep. , 1999, The Journal of clinical endocrinology and metabolism.
[9] M. Pfeffer,et al. Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein , 1999 .
[10] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[11] J. Sipe,et al. Analytical Evaluation of Particle-Enhanced Immunonephelometric Assays for C-Reactive Protein, Serum Amyloid a and Mannose-Binding Protein in Human Serum , 1998, Annals of clinical biochemistry.
[12] A. Gerbig,et al. Circadian elevation of IL-6 levels in Muckle-Wells syndrome: a disorder of the neuro-immune axis? , 1998, QJM : monthly journal of the Association of Physicians.
[13] R J Glynn,et al. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. , 1998, Circulation.
[14] J. Born,et al. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. , 1998, The Journal of clinical endocrinology and metabolism.
[15] P. Deuster,et al. Exercise and Circadian Rhythm-Induced Variations in Plasma Cortisol Differentially Regulate Interleukin-1β (IL-1β), IL-6, and Tumor Necrosis Factor-α (TNFα) Production in Humans: High Sensitivity of TNFα and Resistance of IL-6 , 1997 .
[16] J. Born,et al. Effects of sleep and circadian rhythm on human circulating immune cells. , 1997, Journal of immunology.
[17] P. Ridker,et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.
[18] F. Holsboer,et al. Diurnal variations in the human host response to endotoxin. , 1996, The Journal of infectious diseases.
[19] P. Zabel,et al. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines. , 1996, American journal of respiratory and critical care medicine.
[20] J. Weatherbee,et al. Circadian characteristics of circulating interleukin-6 in men. , 1995, The Journal of allergy and clinical immunology.
[21] R. Sothern,et al. Circadian rhythmometry of serum interleukin-2, interleukin-10, tumor necrosis factor-alpha, and granulocyte-macrophage colony-stimulating factor in men. , 1995, Chronobiology international.
[22] H. Groen,et al. Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study. , 1994, Blood.
[23] M. Pepys,et al. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. , 1993, The Journal of clinical investigation.
[24] R C Hermida,et al. Chronolab: an interactive software package for chronobiologic time series analysis written for the Macintosh computer. , 1992, Chronobiology international.
[25] P. Heinrich,et al. Acute‐phase response of human hepatocytes: Regulation of acute‐phase protein synthesis by interleukin‐6 , 1990, Hepatology.
[26] J V Castell,et al. Interleukin-6 and the acute phase response. , 1990, The Biochemical journal.
[27] M. Herold,et al. Circadian rhythm of C-reactive protein in patients with rheumatoid arthritis. , 1987, Progress in clinical and biological research.
[28] M. Pepys,et al. C-reactive protein: binding to lipids and lipoproteins. , 1985, International review of experimental pathology.
[29] H. Bird,et al. Circadian variation in biochemical assessments used to monitor rheumatoid arthritis. , 1984, Annals of the rheumatic diseases.
[30] I. Kushner,et al. SERUM C‐REACTIVE PROTEIN LEVELS IN DISEASE * , 1982, Annals of the New York Academy of Sciences.
[31] D. Karp,et al. Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction. , 1978, The Journal of clinical investigation.
[32] T F Gallagher,et al. Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. , 1971, The Journal of clinical endocrinology and metabolism.